Bo Yang

Bo Yang

Auto-generated profile, based on publicly available information

Bo Yang

Department of Cardiac Surgery, University of Michigan, Ann Arbor, MI 48109, USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2019 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
BYBo Yang
Bo Yang
ENElizabeth L. Norton
Elizabeth L. Norton
CRCarlo Maria Rosati
Carlo Maria Rosati
XWXiaoting Wu
Xiaoting Wu
KKKaren M. Kim
Karen M. Kim
HPHimanshu J. Patel
Himanshu J. Patel

6 November 2018 in Circulation
Verified
Journal Article
Open access
PDF file
BYBo Yang
Bo Yang
CRCarlo Maria Rosati
Carlo Maria Rosati
ENElizabeth L. Norton
Elizabeth L. Norton
KKKaren M. Kim
Karen M. Kim
MKMinhaj S. Khaja
Minhaj S. Khaja
DWDavid M. Williams
David M. Williams
Background: Immediate open repair of acute type A aortic dissection is traditionally recommended to prevent death from aortic rupture. However, organ failure because of malperfusion syndrome (MPS) might be the most imminent life-threatening problem for a subset of patients. Methods: From 1996 to 2017, among 597 patients with acute type A aortic dissection, 135 patients with MPS were treated with upfront endovascular reperfusion (fenestration/stenting) followed by delayed open repair (OR). We compared outcomes between the first and second decades and observed mortalities with those expected with an “upfront OR for every patient” approach, determined using prognostic models from the literature (Verona, Leipzig-Halifax, Stockholm, Penn, and GERAADA [German Registry for Acute Aortic Dissection Type A] models). Results: Overall, in-hospital mortality improved between the 2 decades (21.0% versus 10.7%, P <0.001). In the second decade, for patients with MPS initially treated with fenestration/stenting, mortality from aortic rupture decreased from 16% to 4% ( P =0.05), the risk of dying from organ failure was 6.6 times higher than dying from aortic rupture (hazard ratio=6.63; 95% CI, 1.5–29; P =0.01), and 30-day mortality after OR for MPS patients was 3.7%. Compared to the expected mortalities with the upfront OR for every patient models, our observed 30-day and in-hospital mortalities (9% and 11%, respectively) of all patients with acute type A aortic dissection were significantly lower ( P ≤0.03). Conclusions: Immediate OR is the strategy to prevent death from aortic rupture for the majority of patients with acute type A aortic dissection. However, relatively stable (no rupture, no tamponade) patients with MPS benefit from a staged approach: upfront endovascular reperfusion followed by aortic OR at resolution of organ failure.

25 May 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
BYBo Yang
Bo Yang
WZWei Zhou
Wei Zhou
JJJiao Jiao
Jiao Jiao
JNJonas B. Nielsen
Jonas B. Nielsen
MMMichael R. Mathis
Michael R. Mathis
CWCristen J. Willer
Cristen J. Willer
Bicuspid aortic valve (BAV) is a heritable congenital heart defect and an important risk factor for valvulopathy and aortopathy. Here we report a genome-wide association scan of 466 BAV cases and 4,660 age, sex and ethnicity-matched controls with replication in up to 1,326 cases and 8,103 controls. We identify association with a noncoding variant 151 kb from the gene encoding the cardiac-specific transcription factor, GATA4, and near-significance for p.Ser377Gly in GATA4. GATA4 was interrupted by CRISPR-Cas9 in induced pluripotent stem cells from healthy donors. The disruption of GATA4 significantly impaired the transition from endothelial cells into mesenchymal cells, a critical step in heart valve development.

1 June 2019 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
BYBo Yang
Bo Yang
ENElizabeth L. Norton
Elizabeth L. Norton
RHReilly Hobbs
Reilly Hobbs
LFLinda Farhat
Linda Farhat
XWXiaoting Wu
Xiaoting Wu
GDG. Michael Deeb
G. Michael Deeb

1 February 2021 in JTCVS Techniques
Verified
Journal Article
Open access
BYBo Yang
Bo Yang

1 November 2022 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
GZGuizhen Zhao
Guizhen Zhao
YZYang Zhao
Yang Zhao
Haocheng LuHaocheng Lu
Haocheng Lu
ZCZiyi Chang
Ziyi Chang
HLHongyu Liu
Hongyu Liu
JZJifeng Zhang
Jifeng Zhang
Abdominal aortic aneurysm (AAA) is a life-threatening vascular disease. BAF60c, a unique subunit of the SWItch/sucrose nonfermentable (SWI/SNF) chromatin remodeling complex, is critical for cardiac and skeletal myogenesis, yet little is known about its function in the vasculature and, specifically, in AAA pathogenesis. Here, we found that BAF60c was downregulated in human and mouse AAA tissues, with primary staining to vascular smooth muscle cells (VSMCs), confirmed by single-cell RNA-sequencing. In vivo studies revealed that VSMC-specific knockout of Baf60c significantly aggravated both angiotensin II– (Ang II–) and elastase-induced AAA formation in mice, with a significant increase in elastin degradation, inflammatory cell infiltration, VSMC phenotypic switch, and apoptosis. In vitro studies showed that BAF60c knockdown in VSMCs resulted in loss of contractile phenotype, increased VSMC inflammation, and apoptosis. Mechanistically, we demonstrated that BAF60c preserved VSMC contractile phenotype by strengthening serum response factor (SRF) association with its coactivator P300 and the SWI/SNF complex and suppressing VSMC inflammation by promoting a repressive chromatin state of NF-κB target genes as well as preventing VSMC apoptosis through transcriptional activation of KLF5-dependent B cell lymphoma 2 (BCL2) expression. Our identification of the essential role of BAF60c in preserving VSMC homeostasis expands its therapeutic potential in preventing and treating AAA.